BDBM15861 1-{[2-(4-chlorophenyl)-1,3-thiazol-5-yl]methyl}-N-[1-(propan-2-yl)piperidin-4-yl]-1H-indole-2-carboxamide::2-carboxyindole 21

SMILES CC(C)N1CCC(CC1)NC(=O)c1cc2ccccc2n1Cc1cnc(s1)-c1ccc(Cl)cc1

InChI Key InChIKey=FTRYLMSDUSKCSS-UHFFFAOYSA-N

Data  1 KI

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 15861   

TargetCoagulation factor X(Human)
Aventis Pharma Deutschland

LigandPNGBDBM15861(1-{[2-(4-chlorophenyl)-1,3-thiazol-5-yl]methyl}-N-...)
Affinity DataKi:  2.73E+3nM ΔG°:  -7.58kcal/molepH: 7.8 T: 2°CAssay Description:The inhibitory effect of test compound for human fXa was determined by using the chromogenic substrates S-2765. The hydrolysis rates of chromogenic s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/27/2007
Entry Details Article
PubMed